ClinicalTrials.gg
CompletedNCT07807332CaknaStrokUpdated Sep 10, 2026

CaknaStrok Education Package for Stroke Caregivers

An interventional study of CaknaStrok Education Package (CEP) in Stroke, Caregiving Burden and Caregiver, sponsored by Clinical Research Centre, Malaysia. Completed at 1 site in Malaysia. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by Clinical Research Centre, Malaysia · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 11 months after the study started (first participant enrolled Oct 2024, registered Sep 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
113
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluated the feasibility and potential effectiveness of the CaknaStrok Education Package (CEP), a culturally tailored education package developed to support informal caregivers of stroke survivors. The package consists of a mobile health application and a Malay-language caregiving guidebook covering stroke knowledge, caregiving strategies, rehabilitation, nutrition, secondary prevention and caregiver self-care. The study compared caregivers receiving the CaknaStrok Education Package in addition to usual care with those receiving usual care alone. The study assessed outcomes related to caregiving burden, quality of life and psychological well-being, as well as the feasibility of implementing the intervention within routine stroke care.

Read the detailed description

The CaknaStrok Education Package (CEP) is a culturally tailored, blended digital and print educational intervention developed to support informal caregivers of stroke survivors in Malaysia. The intervention consists of the CaknaStrok mobile application and a Malay-language caregiving guidebook. The mobile application provides video-based caregiving guidance, stress self-assessment, Barthel Index tracking, stroke-related resources and communication with the research team. The guidebook consists of six modules covering stroke knowledge, caregiving strategies, rehabilitation exercises, nutrition, secondary prevention and caregiver self-care.

This study adopted a feasibility cluster randomized trial design and was conducted at six hospitals representing different regions of Malaysia: Hospital Raja Perempuan Zainab II, Hospital Sultanah Nur Zahirah, Hospital Seberang Jaya, Hospital Umum Sarawak, Hospital Sultanah Aminah and Hospital Sungai Buloh. The study was conducted from 1 October 2024 to 31 August 2025.

Informal caregivers of stroke survivors were recruited during the patients' hospital admission. Eligible caregivers were adults aged 18 years or older who were spouses, family members or relatives providing informal care to stroke patients with acute stroke and a Modified Rankin Scale score of 4-5.

Participants in the intervention group received the CaknaStrok Education Package in addition to usual care, while participants in the control group received usual caregiver education provided as part of routine clinical care.

The study evaluated the feasibility of the intervention and its potential effects on caregivers' psychosocial outcomes, including caregiving burden, quality of life and psychological well-being.

02

Conditions studied

  • Stroke
  • Caregiving Burden
  • Caregiver
  • Caregiver Burden for Those Who Care for Adults With Impaired Functional Status
  • Caregiver Mental Health
  • Caregiver Quality of Life
  • Caregiver Burden
  • Caregiver Participation
  • mHealth Intervention
  • mHealth

Keywords

  • Stroke
  • Stroke caregivers
  • Informal Caregivers
  • mHealth
  • Caknastrok
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's enrollment of 113 is above the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Clinical Research Centre, Malaysia is the lead sponsor of 30 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged ≥18 years.
  • Spouse, family member, or relative of the stroke patient.
  • Informal caregiver of a patient diagnosed with acute stroke (within 14 days of stroke onset) with a Modified Rankin Scale (mRS) score of 4-5.
  • Present during the patient's hospital admission.
  • No prior caregiving experience before the current stroke event.
  • Residing at home with the stroke patient.

Exclusion criteria

Exclusion Criteria:

  • Non-Malaysian/non-citizen.
  • Maid, employee, or paid caregiver.
  • Unavailable during the study period.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
113 participants (actual)

Study arms

  • Experimental
    CaknaStrok Education Package

    Participants received the CaknaStrok Education Package in addition to usual care. The package comprised the CaknaStrok mobile application and a Malay-language printed caregiving guidebook, providing education and support on stroke care, rehabilitation, nutrition, secondary prevention, and caregiver self-care.

    Behavioral: CaknaStrok Education Package (CEP)

  • No intervention
    Usual Care

    Participants received the usual stroke care and caregiver education provided as part of routine clinical practice, without the CaknaStrok Education Package.

Interventions

  • BehavioralCaknaStrok Education Package (CEP)

    The CaknaStrok Education Package (CEP) is a culturally tailored blended digital and print intervention for Malaysian stroke caregivers. It comprises a trilingual mobile application (Malay, English and Mandarin) with caregiving videos, stress self-assessment, Barthel Index tracking, stroke resources and communication with the research team, together with a Malay-language guidebook covering stroke knowledge, caregiving strategies, rehabilitation, nutrition, secondary prevention and caregiver self-care. Participants received a briefing and hands-on training for app installation and use, with technical assistance as needed, and continued access to the CEP for three months.

06

What researchers measure

Primary outcomes

  1. Recruitment Rate

    Number and proportion of eligible caregivers who consented to participate in the study.

    Time frame: From initiation of recruitment until completion of recruitment

  2. Participant Retention Rate

    Proportion of enrolled participants who completed the scheduled follow-up assessments.

    Time frame: Months 1, 2, and 3 after baseline

  3. Outcome Measure Completion Rate

    Proportion of participants who completed the scheduled outcome assessments.

    Time frame: Baseline and Months 1, 2, and 3

Secondary outcomes

  1. Caregiver Burden

    Caregiver burden was assessed using the Malay Zarit Burden Interview (MZBI), a 22-item scale with total scores ranging from 0 to 88, with higher scores indicating greater caregiver burden (worse outcome).

    Time frame: Baseline, Month 1, Month 2, and Month 3

  2. Quality of Life (WHOQOL-BREF)

    Quality of life was assessed using the Malay World Health Organization Quality of Life-BREF (WHOQOL-BREF), comprising four domains: Physical Health, Psychological Health, Social Relationships, and Environment. Each domain is scored on a 0-100 scale, with higher scores indicating better quality of life.

    Time frame: Baseline, Month 1, Month 2, and Month 3

  3. Psychological Well-Being

    Psychological well-being was assessed using the Depression Anxiety and Stress Scale-21 (DASS-21), comprising three subscales: Depression, Anxiety, and Stress. Each subscale consists of 7 items, with scores ranging from 0 to 21 (or 0-42 when multiplied by 2), with higher scores indicating greater psychological distress (worse outcome).

    Time frame: Baseline, Month 1, Month 2, and Month 3

07

Study locations

1 site
  • Hospital Raja Perempuan Zainab II (HRPZ), Kelantan Hospital Sultanah Nur Zahirah (HSNZ), Terengganu Hospital Seberang Jaya, Penang Hospital Umum Sarawak, Sarawak Hospital Sultanah Aminah, Johor Hospital Sungai Buloh, Selangor
    Kuala Terengganu, Terengganu 21400, Malaysia
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual participant-level data will not be shared to protect participant confidentiality and comply with applicable data protection and ethical requirements.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in May 2025, 7 months.

Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 7 months is below that.

Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2026
First posted
Sep 8, 2026
StartActual
Oct 1, 2024
Primary completionActual
May 31, 2025
CompletionActual
Aug 31, 2025
Last update
Sep 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07807332
Lead sponsor
Clinical Research Centre, Malaysia
Responsible party
NORSIMA NAZIFAH BINTI SIDEK (Research Pharmacist, Clinical Research Centre, Malaysia) — Principal investigator
First posted
Sep 8, 2026
Start date
Oct 1, 2024
Primary completion
May 31, 2025
Completion
Aug 31, 2025
Last update
Sep 10, 2026

Study contacts

KAMARUL IMRAN MUSA, PhD
study director · Universiti Sains Malaysia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion